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Abstract
Background: Amoebic liver abscess (ALA) and pyogenic liver abscesses (PLA) appear identical by
ultrasound and other imaging techniques. Collection of blood or liver abscess pus for diagnosis of
liver abscesses is an invasive procedure, and the procedure requires technical expertise and
disposable syringes. Collection of urine is a noninvasive procedure. Therefore, there has been
much interest shown towards the use of urine as an alternative clinical specimen for the diagnosis
of some parasitic infections. Here, we report for the first time the detection of E. histolytica DNA
excreted in the urine for diagnosis of the cases of ALA.
Results: E. histolytica DNA was detected in liver abscess pus specimen of 80.4% of ALA patients
by a nested multiplex polymerase chain reaction (PCR) targeting 16S-like r RNA gene. The nested
PCR detected E. histolytica DNA in all 37 (100%) liver abscess pus specimens collected prior to
metronidazole treatment, but were detected in only 53 of 75 (70.6%) pus specimens collected after
therapy with metronidazole. Similarly, the PCR detected E. histolytica DNA in 21 of 53 (39.6%) urine
specimens of ALA patients. The test detected E. histolytica DNA in only 4 of 23 (17.4%) urine
specimens collected prior to metronidazole treatment, but were detected in 17 of 30 (56.7%) urine
specimens collected after treatment with metronidazole. The enzyme-linked immunosorbent assay
(ELISA) for the detection of lectin E. histolytica antigen in the liver abscess pus showed a sensitivity
of 50% and the indirect haemagglutination (IHA) test for detection of amoebic antibodies in the
serum showed a sensitivity of 76.8% for the diagnosis of the ALA.
Conclusion: The present study for the first time shows that the kidney barrier in ALA patients is
permeable to E. histolytica DNA molecule resulting in excretion of E. histolytica DNA in urine which
can be detected by PCR. The study also shows that the PCR for detection of E. histolytica DNA in
urine of patients with ALA can also be used as a prognostic marker to assess the course of the
diseases following therapy by metronidazole. The detection of E. histolytica DNA in urine specimen
of ALA patients provides a new approach for the diagnosis of ALA.
Background
Infection with Entamoeba histolytica, results in 34 million
to 50 million symptomatic cases of amoebiasis worldwide
each year, causing 40 to 100 thousand deaths annually
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[1]. Mortality from amoebiasis is mainly due to extra-
intestinal pathology, of which amoebic liver abscess
(ALA) is the most common. If left untreated, ALA can rup-
ture into neighboring tissue and spread to the brain and
other organs via hematological route producing serious
morbidity and mortality. It is difficult to differentiate clin-
ically the ALA from pyogenic liver abscess (PLA) as well as
from other space occupying lesions of liver such as
hydatid cyst and liver hepatoma [2,3].
Imaging techniques like ultrasound, computed tomogra-
phy, and magnetic resonance although are highly sensi-
tive to detect abscesses in the liver of varied aetiology,
however fail to distinguish specifically ALA from that of
PLA. Less than one third of patients with ALA have active
diarrhea [3]. Hence, stool microscopy and stool antigen
detection is not very helpful for diagnosis of ALA. In fact
less than only 10% of ALA patients have identifiable E.
histolytica in stool specimens [4].
Laboratory diagnosis of ALA is usually established by con-
ventional antibody-based serological tests. Nevertheless,
the main disadvantage with antibody detection is that
serum antibody levels in individuals living in endemic
areas, continues to remain positive even for years after
infection with E. histolytica [5-7]. The demonstration of
amoebic antibodies in the serum, therefore, fails to
denote the amoebic infection whether it is recent or old.
Furthermore, serum amoebic antibodies are not demon-
strated in up to 10% of the patients with acute ALA [3].
The demonstration of E. histolytica trophozoite in liver
abscess pus aspirates by microscopy confirms the diagno-
sis of ALA, but in best of the laboratories, the amoebic tro-
phozoites can be demonstrated in only 15% of the liver
pus [8]. Since the trophozoites of E. histolytica are found
mainly in the periphery of the abscess diagnosis of ALA by
culture of liver pus for E. histolytica is also unsatisfactory
[9].
Demonstration of amoebic antigen in the liver pus is a
recent approach for specific diagnosis of the ALA. A mon-
oclonal antibody-based second generation TechLab
enzyme-linked immunosorbent assay (ELISA) kit (Blacks-
burg, Va.) has been reported to be 78% sensitive for the
detection of E. histolytica lectin antigen in the liver pus for
the diagnosis of ALA in Dhaka, Bangladesh [10]. Studies
conducted in various laboratories worldwide including
ours have shown that polymerase chain reaction (PCR) is
a sensitive and specific method for detecting Entamoeba
DNA in stool samples and for differentiating the morpho-
logically similar E. histolytica from Entamoeba dispar and
Entamoeba moshkovskii [11-19]. However, only few studies
using the PCR have been reported for the detection of
Entamoeba DNA in liver abscess pus for the diagnosis of
the ALA [20,21,9,10].
Collection of blood or liver abscess pus is an invasive pro-
cedure, and the procedures require technical expertise and
disposable syringes [22]. The method if not carried out
under stringent conditions is associated with the risk of
acquiring needle-borne infections such as hepatitis B virus
and human immunodeficiency virus (HIV). Therefore, of
late much interest has been shown towards the use of
urine as a specimen alternate to the blood for the diagno-
sis of some parasitic infections including malaria, schisti-
somiasis, kala-azar, cystic echinococcosis and
neurocysticercosis [22]. Urinary antigen for cystic echino-
coccosis (CE) and neurocysticercosis has been reported
for the first time from our laboratory at Jawaharlal Insti-
tute of Postgraduate Medical Education and Research (JIP-
MER), Puducherry, India [23,24]. Our laboratory has
developed for the first time a counter-current immunoe-
lectrophoresis (CIEP) and co-agglutination (Co-A) to
detect the hydatid antigen excreted in the urine for the
diagnosis of CE [23,25], and Co-A to detect cysticercus
antigen in the urine for the diagnosis of neurocysticercosis
[24].
Detection of DNA in urine by PCR has been employed for
the diagnosis of Toxoplasma gondii, Neisseria gonorrhoeae,
Borrelia burgdorferi, Mycobacterium tuberculosis, Mycobacte-
rium leprae and Chlamydia trachomatis infections [26-30].
Some studies have also shown that the kidney barrier in
rodents and humans is permeable to DNA molecules large
enough to be analyzed by standard genetic methodologies
[31,32]. To the best of our knowledge till now there is no
report available on detection of Entamoeba DNA in the
urine for the diagnosis of ALA. In the present study, there-
fore for the first time, we have evaluated a nested multi-
plex PCR for detection of Entamoeba DNA excreted in the
urine for the diagnsosis of ALA.
Results
The quantification of DNA in the liver abscess pus and
urine specimen by Spectrophotometric analysis showed
the DNA yield to be approximately 85 and 3 μg/ml respec-
tively. The purity of DNA extract from liver abscess pus
and urine specimens was found to be satisfactory as the
value of ratio of readings at 260 nm and 280 nm (OD260/
OD280) was approximately 1.8–1.85.
The sequencing result of PCR product of E. histolytica from
liver abscess pus and urine specimen showed 99% identi-
ties to the sequence deposited in GenBank, [accession
number: X56991]. The result of assessment of competi-
tion of other non target DNA present in liver abscess pus
(PLA pus negative for E. histolytica) and urine (negative
control group) specimen with target DNA, showedBMC Microbiology 2007, 7:41 http://www.biomedcentral.com/1471-2180/7/41
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expected amplification and no nonspecific amplification
in nested multiplex PCR.
Estimation of minimum number of Entamoeba  cells
detectable by nested multiplex PCR showed that the
detection limit of PCR was found to be approximately 15
E. histolytica cells as even 1.5 μl of template DNA from
1000 E. histolytica cells/100 μl of Tris- ethylenediamine
tetraacetic acid (EDTA) (TE) buffer produced a positive
signal.
The IHA test was positive for serum antibodies in the
serum of 86 (61.9%) of 139 patients provisionally diag-
nosed as ALA. The test was positive in a higher number of
serum (71 of 102 [69.6%]) samples of patients who had
received prior treatment with metronidazole than those
who had not received any prior treatment with metroni-
dazole (15 of 37 [40.5%]) and this difference was statisti-
cally significant (χ2 = 8.53, P = 0.003). Metronidazole
treatment was initiated from a few days to several weeks
before collection of the blood samples in these patients.
Two (4.6%) out of 43 sera from control cases were posi-
tive for antiamoebic antibody by IHA.
The TechLab E. histolytica II test was positive for E. histolyt-
ica Gal/GalNAc lectin antigen in the liver abscess pus of
56 (40.3%) of 139 provisionally diagnosed ALA patients.
The TechLab E. histolytica II test detected lectin antigen in
30 (81%) of 37 liver abscess pus of patients which were
collected prior to treatment with metronidazole. In con-
trast, the TechLab E. histolytica test detected the lectin anti-
gen in only 26 (25.5%) of 102 liver pus (χ2 = 32.61, P <
0.001), collected after initiation of therapy with metroni-
dazole. The probability of E. histolytica antigen detection
in liver abscess pus by ELISA was found to be 12 times
more in patients who had not received prior treatment
with metronidazole (Odds Ratio (OR) = 12.53, 95% Con-
fidence Interval (CI) = 4.55 to 35.86) than in the patients
who received prior metronidazole therapy. The OR was
statistically significant as the 95% CI of OR was more than
1.
Microscopy of the liver pus demonstrated E. histolytica tro-
phozoites in 10 of 139 (7.2 %) liver abscess specimens,
but only 2 (1.4%) pus specimens were positive by culture
for E. histolytica. All 10 patients whose liver pus were pos-
itive for E. histolytica by microscopy and/or culture were
also positive for E. histolytica Gal/GalNAc lectin antigen in
the liver pus by the TechLab E. histolytica II test and serum
amoebic antibodies by the IHA test.
A total of 102 out of 139 (73.4%) liver abscess pus were
negative for aerobic bacteria by Gram's staining and bac-
terial culture. Twenty seven liver abscess pus specimens
were positive for aerobic bacteria by Gram's staining and
bacterial culture. These included Klebsiella pneumoniae (n
= 9), Proteus  species (n = 5), Enterobacter  (n = 5),
Escherichia coli (n = 3) and Pseudomonas (n = 5). Ten liver
abscess pus specimens showed secondary infection of ALA
with aerobic bacteria by Gram's staining and bacterial cul-
ture. These included K. pneumoniae (n = 3), Enterobacter (n
= 2), E. coli (n = 1), group B Salmonella species (n = 1),
Enterococcus (n = 1) and Coagulase negative Staphylococci
(n = 2). Such secondary infection of ALA with bacteria has
been reported previously in the literature [33,34].
In the present study, a total of 112 out of 139 (80.6%)
provisionally diagnosed ALA patients were diagnosed as
ALA and remaining 27 patients were diagnosed as PLA, by
following the criteria mentioned in this study elsewhere.
The result of nested multiplex PCR performed on the liver
abscess pus is depicted in Figure 1. The nested multiplex
PCR test was positive for E. histolytica DNA in 90 (80.4%)
of 112 liver abscess pus specimens (Table 1). The nested
multiplex PCR could detect E. histolytica DNA in the liver
abscess pus of all 37 ALA patients (100%), who were
tested prior to treatment with metronidazole. In contrast,
prior metronidazole treatment significantly decreased the
ability of the PCR to detect E. histolytica DNA in the liver
abscess pus, with only 53 (70.6%) of 75 liver pus samples
positive (Fisher's Exact test, P = 0.0006). The probability
of  E. histolytica DNA detection in liver abscess pus by
nested multiplex PCR was 31 times more in patients who
had not received prior metronidazole therapy (OR =
31.54, 95% CI = 1.879 to 624.2) than in the patients who
received prior metronidazole therapy. The OR was statis-
tically significant as the 95% CI of OR was greater than 1.
The nested multiplex PCR did not detect E. histolytica DNA
in a total of 49 liver abscess pus specimens, which
included 27 PLA and 22 ALA pus specimens. The proba-
bility of negative nested multiplex PCR results, in these 49
liver abscess pus specimens due to PCR inhibitors was
ruled out by the inclusion of an internal amplification
control (IAC) in the nested PCR reaction.
The comparison of results of nested multiplex PCR and
TechLab E. histolytica II ELISA test on liver abscess pus
from ALA patients is summarised in the table 1.
The nested multiplex PCR result on urine specimen is
shown in Figure 1. The nested multiplex PCR was per-
formed on urine specimen collected from 68 patients
(including 53 ALA and 15 PLA) and 43 controls. The
nested multiplex PCR test detected E. histolytica DNA in 21
(39.6%) of 53 urine samples collected from patients with
ALA (Table 2). The test did not detect E. histolytica DNA in
urine samples collected from all 15 PLA patients and 43
controls.BMC Microbiology 2007, 7:41 http://www.biomedcentral.com/1471-2180/7/41
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The nested multiplex PCR test detected E. histolytica DNA
in the urine specimens of 4 (17.4%) of 23 ALA patients
who were tested prior to treatment with metronidazole
and in 17 (56.7%) of 30 ALA patients who were tested
after treatment with metronidazole (χ2 = 6.83, P = 0.009).
All of the 4 ALA patients, who did not receive prior treat-
ment with metronidazole and whose urine specimens
were positive for E. histolytica DNA, were available for fol-
low-up study. Urine specimens were collected from these
patients every week for 4 weeks after starting of the ther-
apy with metronidazole; and were tested for E. histolytica
DNA by PCR. It was observed that 2 weeks after treatment
with metronidazole, 3 (75%) out of 4 urine specimens
became negative for E. histolytica DNA. One urine speci-
men became negative for E. histolytica DNA after 4 weeks
of treatment with metronidazole.
Discussion
In this study, we have made an attempt to detect excretory
E. histolytica DNA in urine by applying nested multiplex
PCR and to assess the diagnostic potential of the test for
detection of E. histolytica DNA in urine for the diagnosis of
ALA. Also we have studied the kinetics of the excretion of
E. histolytica DNA in urine during the course of therapy
with metronidazole.
In our study, 76.8% (86 of 112) of ALA patients were pos-
itive for antiamoebic antibody in serum by the IHA. This
result was similar to that reported from Bangladesh where
serum antiamoebic antibodies were found in 78% of ALA
patients [10], but differed from that of the study reported
from South Africa, where serum antiamoebic antibodies
were found in a higher 99% of ALA patients [35].
Only two out of 10 ALA pus samples which were positive
for E. histolytica trophozoite by microscopy were positive
for the amoebae by culture and the rest were negative, this
may be due to the inhibition of growth by culture itself. In
majority of patients, K. pneumoniae was the major bacte-
rial pathogen responsible for PLA and as secondary bacte-
rial infection of ALA. One of 10 ALA pus specimens was
positive for Group B Salmonella species, this patient had
liver abscess with perihepatic collection, with severe sepsis
and disseminated intravascular coagulation, finally the
patient died. In this study, the anaerobic culture of liver
abscess pus aspirate was not done. Therefore, the possible
etiology of liver abscess due to anaerobic organisms such
as Bacteroides remained undetermined.
In the present study, 50% (56 of 112) of liver abscess pus
were positive for E. histolytica lectin antigen. The sensitiv-
ity of the test in our study was observed to be slightly
higher than that of the study using the same TechLab E.
histolytica II kit (40.7 % sensitiivty) on liver pus reported
from Bangladesh [10]. However, results of other studies
using polyclonal antibody based ELISA showed a very
high sensitivity for the detection of amoebic antigen in the
liver pus. Amoebic antigen was detected in liver abscess
pus in 97.6% (41/42) of ALA cases by ELISA as reported
from China [21] and in 92% and 96% of liver pus by
Result of nested multiplex PCR on representative liver  abscess pus and urine specimen Figure 1
Result of nested multiplex PCR on representative liver 
abscess pus and urine specimen. The E. histolytica (EH) and 
Internal amplification control (IAC) bands are 439 and 305 
bp respectively. Lane-1 and 4 are positive for E. histolytica 
DNA in liver abscess pus and urine specimen respectively; 
Lane-2, 3 and 5 are negative for E. histolytica DNA; Lane-M, 
100 bp DNA ladder (Bangalore genei, Bangalore).
Table 1: Comparison of result of PCR and antigen detection in liver abscess pus specimen of ALA patients.
PCR results Antigen detection result (no. of specimens positive)
E. histolytica Antigen negative Total no. of specimens
E. histolytica 55a 35 90
Negative 1 21 22
Total 56 56 112
a E. histolytica was detected by microscopy and/or culture in 10 of these 55 ELISA and PCR positive liver abscess pus specimens.BMC Microbiology 2007, 7:41 http://www.biomedcentral.com/1471-2180/7/41
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using immunoelectrophoresis and ELISA respectively,
from India [36].
In developing countries like India where amoebiasis is
endemic, antiamoebic drugs and antibiotics are used
indiscriminately, making it difficult to obtain an accurate
treatment history. Most of the patients in the present
study had already been treated with metronidazole at the
time of collection of clinical specimens. The serum amoe-
bic antibodies were detected in higher percentage (94.7%)
of ALA patients treated earlier with metronidazole, but
were detected in only 40.5% of patients who did not
receive any prior treatment with metronidazole. This
might be due to the late antibody response during the
course of the disease.
Unlike serum amoebic antibody detection, E. histolytica
lectin antigen was detected in liver pus by TechLab ELISA
in a higher percentage (81%) of ALA patients, who were
tested prior to treatment with metronidazole, but was
detected in only 34.6% of ALA patients, who were tested
after the initiation of therapy with metronidazole. This
might be due to the rapid clearing of amoebic antigen
from the liver pus due to killing of E. histolytica tropho-
zoites on treatment with metronidazole.
The PCR for the detection of E. histolytica DNA in liver
abscess pus had a much higher sensitivity (100%) when
tested prior to treatment with metronidazole, but had a
lower sensitivity (70.6%) when tested after the initiation
of treatment with metronidazole. This might be attributed
to the clearing of E. histolytica DNA from the liver abscess
due to the death and lysis of E. histolytica trophozoites on
treatment with metronidazole. The percentage of agree-
ment between E. histolytica DNA detection and ELISA for
E. histolytica antigen detection in liver abscess pus was
found to be 67.9% in the present study (Table 1). The
Kappa statistic was found to be 0.36 which indicates a fair
agreement between the two tests.
PCR for detection of E. histolytica DNA and ELISA for
detection of E. histolytica lectin antigen in liver abscess pus
were evaluated for the diagnosis of ALA (McNemar's χ2 =
30.25, p < 0.0001). The sensitivity of PCR was 80.4%. This
was found to be significantly higher than that of ELISA
(50 %) using McNemar's χ2 test (p < 0.0001). All 27 liver
abscess pus aspirates diagnosed as PLA were negative for
E. histolytica DNA by PCR and for E. histolytica lectin anti-
gen by TechLab ELISA, which represents a specificity of
100%. ELISA for detection of liver abscess pus E. histolytica
lectin antigen demonstrated a 100% positive predictive
value and a 32.5% negative predictive value. PCR for the
detection of liver abscess pus E. histolytica DNA demon-
strated a 100% positive predictive value and a 55.1% neg-
ative predictive value.
In the present study E. histolytica DNA was detected in the
urine specimen of 4 (17.4%) of 23 ALA patients, who
were tested prior to treatment with metronidazole and in
17 (56.7%) of 30 ALA patients, who were tested after
treatment with metronidazole by PCR. The probability of
E. histolytica DNA detection in urine by PCR was 6 times
more in ALA patients who had received prior metronida-
zole therapy (OR = 6.2, 95% CI = 1.47 to 28.37) than in
the ALA patients who did not receive prior metronidazole
therapy. The OR was statistically significant as the 95% CI
of OR was greater than 1. This might be due to release of
increased E. histolytica DNA from the dying E. histolytica
trophozoites when metronidazole therapy was initiated,
leading to excretion of E. histolytica DNA in the urine. One
study has demonstrated that the DNA from dying cells can
cross the kidney barrier in rodents and humans and can
get excreted with urine, which can be used for genetic
analysis [31].
PCR for detection of E. histolytica DNA in liver abscess pus
and urine specimen were evaluated for the diagnosis of
ALA (McNemar's χ2 = 26.28, p < 0.0001). The sensitivity
of PCR for urine was 39.6%. This was found to be signifi-
Table 2: Detection of serum antiamoebic antibody, liver pus E. histolytica antigen, liver pus Entamoeba DNA and urine Entamoeba DNA 
in ALA patients.
No. (%) of positive results by:
IHA for : ELISA for: PCR for:
Diagnosis No of patients
Antiamoebic antibody in 
sera
Amoebic lectin antigen in liver 
pus
Entamoeba DNA in liver pus Entamoeba DNA in urine
E. histolytica E. dispar E. moshkovskii E. histolytica E. dispar E. moshkovskii
(439 bp) (174 bp) (553 bp) (439 bp) (174 bp) (553 bp)
ALAa 53 38 (71.7) 29 (54.7) 51 (96.2) 0 0 21(39.6) 0 0
PLAb 15 0 0 0 0 0 0 0 0
aamoebic liver abscess; bpyogenic liver abscessBMC Microbiology 2007, 7:41 http://www.biomedcentral.com/1471-2180/7/41
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cantly lower than that of PCR for liver abscess pus
(80.4%) using McNemar's χ2 test (p < 0.0001). All urine
specimens from 15 PLA patients and 43 control group
individuals were negative for E. histolytica DNA by PCR.
This represents a specificity of 100% (Table 2). PCR for
the detection of urinary E. histolytica DNA demonstrated a
100% positive predictive value and a 31.9% negative pre-
dictive value.
As per the PCR kinetics the likelihood of amplifying
smaller PCR product is more than amplifying larger PCR
product. We feel that if the PCR product smaller than 400
bp would have been amplified, the PCR might show
higher sensitivity.
E. histolytica DNA in urine did not persist longer in ALA
patients after treatment with metronidazole as observed
in the present study. Three of 4 (75%) urine specimens
positive for E. histolytica DNA became negative for E. his-
tolytica DNA within 2 weeks of treatment with metronida-
zole. This might be attributed to the reduced excretion of
E. histolytica DNA in the urine as a result of reduction of E.
histolytica infection load following treatment with metro-
nidazole. The effect of metronidazole in killing of E. histo-
lytica and clearing of antigenemia in hamsters suffering
from hepatic amoebiasis has been well documented in a
study reported by Thammapalerd et al. [37] Results of the
present study therefore indicate that the PCR can be used
to monitor excretion of E. histolytica DNA in urine as a
prognostic marker during therapy of ALA with specific
antiamoebic drugs.
In the present study, none of the liver abscess pus and
urine PCR results were positive for either E. dispar or E.
moshkovskii specific PCR products, which confirm the non
invasive nature of these species (Table 2).
The detection of E. histolytica DNA and E. histolytica spe-
cific lectin antigen in the serum specimen of ALA patients
was not carried out in this study. A controlled prospective
study to evaluate the detection of E. histolytica DNA and E.
histolytica specific lectin antigen in the serum specimen of
ALA patients has been intended to be carried out in future
in our laboratory.
Conclusion
The present study for the first time shows that the kidney
barrier in ALA patients is permeable to E. histolytica DNA
molecule resulting in excretion of E. histolytica DNA in
urine which can be detected by PCR. The study also shows
that the PCR for detection of E. histolytica DNA in urine of
patients with ALA can also be used as a prognostic marker
to assess the course of the diseases following therapy by
metronidazole. The detection of E. histolytica DNA in
urine specimen of ALA patients provides a new approach
for the diagnosis of ALA.
Methods
Sample details
The subjects in the present study included 139 patients
provisionally diagnosed as ALA, who were admitted to
JIPMER hospital, Puducherry, as well as 43 controls dur-
ing a period from September 2004 to March 2006. The
provisional diagnosis of ALA was made by the physicians
on the basis of patient's history and clinical features,
unfortunately these features are often nonspecific to con-
firm the diagnosis of ALA. Of the 139 provisionally diag-
nosed ALA patients, 102 had received prior treatment and
37 did not receive prior treatment with metronidazole.
The patients and controls were residing in neighboring
area of Puducherry. Informed consent was obtained from
the patients. This study has been performed with the
approval of Institute Research Council of JIPMER,
Puducherry.
The control group included 43 individuals who had no
history of recent dysentery or diarrhea and whose stool
samples were negative for E. histolytica infection by micro-
scopy and culture. Thirty five of the controls were healthy
asymptomatic volunteers, and the other 8 patients
included, hydatid cyst in liver (n = 2), liver hepatoma (n
= 1), liver cirrhosis (n = 3), and viral hepatitis (n = 2).
The diagnosis of ALA was established on the basis of radi-
ological, symptomatological and laboratory criteria as fol-
lows [3,10]: (i) a space-occupying lesion in the liver
diagnosed by ultra sonography and suggestive of abscess,
(ii) clinical symptoms (fever, pain in the right hypochon-
drium (often referred to the epigastrium), lower chest,
back, or tip of the right shoulder), (iii) enlarged and/or
tender liver, usually without jaundice, (iv) raised right
dome of the diaphragm on chest radiograph, (v) improve-
ment after treatment with antiamoebic drugs (e.g., metro-
nidazole) (vi) positive IHA of serum antibody showing a
titer (≥ 1:128) against E. histolytica, (vii) liver aspirate
appeared like anchovy sauce but was bacteriologically
sterile.
Sample collection
Liver abscess pus: The aspiration of liver abscess pus was
indicated only under the following conditions [3]. (i) to
rule out a pyogenic abscess; (ii) the failure to respond clin-
ically in 3 to 5 days; (iii) the threat of imminent rupture;
and (iv) the prevention of rupture of left-lobe abscess into
the pericardium. The liver abscess pus aspirates were per-
formed, only for clinical purposes as judged by the clini-
cians for the patient care and not for the purpose of this
study. Liver abscess pus was obtained under ultrasound
guidance from all 139 provisionally diagnosed ALABMC Microbiology 2007, 7:41 http://www.biomedcentral.com/1471-2180/7/41
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patients and was stored at -20°C in a sterile container
until used.
Urine: Urine specimen could be collected from 68 out of
139 provisionally diagnosed ALA patients and all 43 con-
trol group individuals included in the study. 10 ml of
urine specimen was collected in a sterile container using
aseptic techniques; urine sample was stored at -20°C until
use.
Blood: Blood specimen was collected from all 139 provi-
sionally diagnosed ALA patients and 43 control group
individuals included in the study. Venous blood (5 ml)
was collected in a sterile container; sera were separated
and stored at -20°C until used.
Microscopy for Entamoeba
Liver abscess pus: The specimens were examined immedi-
ately after the aspiration of abscess. The liver abscess pus
was first centrifuged at 2,500 g for 5 mins and a loopful
(usually inoculating needle loop) of sediment was mixed
with a drop of warm saline on a microscope slide. Micro-
scopic examination of an amoebic abscess aspirate from
liver may reveal haematophagous trophozoites.
Culture for Entamoeba
Liver abscess pus: Liver abscess pus specimens were cul-
tured for Entamoeba species in Locke-egg (LE) medium
(NIH modification of Boeck and Drbohlav's medium) as
previously described [38]. The liver abscess pus was first
centrifuged at 2,500 g for 5 mins and a loopful of sedi-
ment was inoculated into the LE medium. It is to be noted
that in case of culturing Entamoeba from liver abscess aspi-
rates, since the abscess is sterile, bacterial flora (ATCC E.
coli) was added before inoculation of amoebae into xenic
culture.
Gram stain and bacterial culture for liver abscess pus 
aspirates
Direct smear Gram staining and bacterial culture was
done for all liver abscess pus aspirates. The liver abscess
pus specimens were inoculated on to sheep blood agar,
MacConkey agar and chocolate agar plates. The MacCo-
nkey agar plates were incubated at 37°C for 18–24 hours
whereas the blood agar and chocolate agar plates were
incubated in a candle jar at 37°C for 48 hours. Based on
the colony morphology and result of culture smears, nec-
essary biochemical tests were done to identify bacteria to
the species level.
TechLab E. histolytica II ELISA test
The TechLab E. histolytica II test was performed on liver
abscess pus specimens to detect E. histolytica as per the
method described earlier [10].
Antiamoebic antibody detection by rapid-IHA test
The Rapid-IHA was performed on serum specimen as per
the method described earlier [39]. Briefly, double alde-
hyde stabilized chick red blood cell (RBC) sensitized with
the amoebic antigen was used in the test. The haemagglu-
tination test was performed on test serum samples includ-
ing known positive and negative control sera in each
batch. The chick RBC settled quickly and their haemagglu-
tination pattern could be determined within 30 to 45 min
of incubation at room temperature with test sera [39]. A
titer of ≥ 1:128 was considered positive for ALA [40].
Extraction of Entamoeba genomic DNA
Liver abscess pus: Briefly, 1 ml of liver abscess pus was
taken in 1.5 ml centrifuge tube and centrifuged at 12, 000
g for 8 minutes. The supernatant was discarded and 50 μl
of pellet was dispersed in 250 μl of lysis buffer (0.25%
sodium dodecyl sulfate (SDS) in 0.1 M EDTA, pH 8.0),
followed by addition of 100 μg/ml of proteinase K. The
lysate was incubated at 55 °C for 2 hours. Then 75 μl of
3.5 M sodium chloride (NaCl) followed by 42 μl of 10%
cetyltrimethylammonium bromide (CTAB)/0.7 M NaCl
(heated to 55 °C) was added. After the components were
mixed, the sample was incubated at 65°C for 30 min. This
was followed by extractions with equal volumes of chlo-
roform and then phenol-chloroform-isoamyl alcohol,
and the DNA was precipitated with ice cold ethanol. The
dried DNA pellet was dissolved in 50 μl of sterile distilled
water.
Urine: Briefly, 10 ml of the urine sample was centrifuged
at 12,000 g for 15 min at 4 °C. The supernatant was dis-
carded and the pellet was suspended in 500 μl of sterile
distilled water. The suspension was boiled for 10 minutes
followed by sudden cooling. Next, 5 μl of proteinase-K
(10 mg/ml) and 60 μl of 10% SDS were added to the sus-
pension and incubated at 65 °C for three hours. Then 80
μl of 5 M NaCl and 20 μl of 10% CTAB were added to the
mixture and incubated at 65 °C for 45 min. This was fol-
lowed by extractions with equal volumes of chloroform
and then phenol-chloroform-isoamyl alcohol. The DNA
was precipitated with ice cold ethanol. The dried DNA pel-
let was dissolved in 50 μl of sterile distilled water.
The protocol for extraction of DNA from liver abscess pus
and urine specimen has been modified in our laboratory
from CTAB DNA extraction protocol originally described
for DNA extraction from amoebic culture [41]. The
extracted DNA from liver abscess pus and urine sample
was passed through DNA clean-up spin columns (Banga-
lore Genei KT-62, Bangalore). The DNA was stored at -20
°C until used.BMC Microbiology 2007, 7:41 http://www.biomedcentral.com/1471-2180/7/41
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Quantification of DNA in liver abscess pus and urine 
specimen
DNA quantification in spin column purified DNA extract
from liver abscess pus and urine specimen was deter-
mined by UV absorbance using a Cintra 5 double beam
Spectrophotometer. DNA yields were calculated on the
basis of UV absorbance × dilution. The purity of the
nucleic acid in the samples was estimated by the ratio of
readings at 260 nm and 280 nm (OD260/OD280).
Primers design
The genus specific primers were designed using nucleotide
sequences of 16S-like rRNA gene of E. dispar, E. histolytica
and E. moshkovskii Laredo deposited in GenBank [acces-
sion number : Z49256], [accession number : X56991] and
[accession number : AF149906] respectively.
The comparison of all the three 16S-like rRNA gene
sequences of E. dispar,  E. histolytica and  E. moshkovskii
Laredo revealed significant differences enough to design
species specific primers. In this study, we have used an
IAC targeting human 18S ribosomal RNA gene to rule out
false-negative results in clinical specimens. All the primers
were designed using Prime3 online software [42]. The
primers used in PCR are shown in Table 3.
Standard strains
Three standard strains used in this study were E. histolytica
HM-1: IMSS, E. dispar SAW760, and E. moshkovskii Laredo
these were used as positive control in the present study.
The lyophilized DNA of these strains was generously
gifted by Dr. C. Graham Clark from London School of
Hygiene & Tropical Medicine, London, UK.
Nested multiplex PCR protocol
Liver abscess pus PCR: For a reaction volume of 25 μl,
comprising 2.5 μl of 10X PCR buffer (Biogene), 2.0 μl of
25 mM MgCl2 (Bangalore genei), 0.75 μl of deoxynucleo-
side triphosphate mix (10 mM each dNTP, Biogene), 0.3
μl (5 IU/μl) of Taq polymerase (Biogene), 10 picomoles of
target DNA primers (IDT) and 5 picomoles of IAC primers
(IDT) were added in genus and species specific PCR. The
template DNA volume was 2 μl for both genus and species
specific PCR. The PCR tubes were finally placed in an
Eppendorf Thermal cycler [Master cycler gradient].
Urine PCR: The PCR mix composition was the same as
described earlier for liver abscess pus PCR, except that 1.0
μl of 25 mM MgCl2 and 2.5 μl of template DNA was
added.
The conditions for genus specific PCR were as follows; the
PCR mix was subjected to an initial denaturation at 96 °C
for 2 minutes, followed by 30 cycles – each consisting of
92 °C for 60 seconds (Denaturation), 56 °C for 60 sec-
onds (Annealing), and 72 °C for 90 seconds (Extension).
Finally one cycle of extension at 72 °C for seven minutes
was performed. In the species specific nested multiplex
PCR (which had multiple primer sets in the same tube),
only the annealing temperature was changed to 48 °C,
leaving the other parameters of the amplification cycles
unchanged.
3.5 μl of the amplification product was separated by elec-
trophoresis through 1.8% agarose gel (Agarose Low EEO,
Bangalore genie products, Bangalore, India) containing
ethidium bromide in 0.5 × Tris-borate-EDTA at 120 V for
45 min and was visualized under UV light for bands of
DNA of appropriate sizes (Figure 1). A negative control
Table 3: Primer sequence used in PCR.
Genus specific primers (First PCR)
Entamoeba genus E-1 5' TAAGATGCACGAGAGCGAAA 3' (forward primer)
E-2 5' GTACAAAGGGCAGGGACGTA 3' (reverse primer)
Species specific primers (Second nested multiplex PCR)
E. histolytica species EH-1 5' AAGCATTGTTTCTAGATCTGAG 3' (forward primer)
EH-2 5' AAGAGGTCTAACCGAAATTAG 3' (reverse primer)
E. moshkovskii species Mos-1 5' GAAACCAAGAGTTTCACAAC 3' (forward primer)
Mos-2 5' CAATATAAGGCTTGGATGAT 3' (reverse primer)
E. dispar species ED-1 5' TCTAATTTCGATTAGAACTCT 3' (forward primer)
ED-2 5' TCCCTACCTATTAGACATAGC 3' (reverse primer)
Internal amplification control (IAC) primer for PCR
Human 18S ribosomal RNA gene IAC-1 5' GGCTTTGGTGACTCTAGATA 3' (forward primer)
IAC-2 5' CGTTAAAGGATTTAAAGTGG 3' (reverse primer)BMC Microbiology 2007, 7:41 http://www.biomedcentral.com/1471-2180/7/41
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reaction was included with each batch of samples ana-
lyzed by PCR.
Primer validation
The primer sequences designed for E. moshkovskii, E. histo-
lytica, E. dispar and Human IAC were subjected to Basic
Local Alignment Search Tool (BLAST) in the genome data-
base of all organisms [43] and were found to be specific
for the study. The amplified PCR products of E. histolytica
species in liver abscess pus and urine samples was con-
firmed by getting both the strands of DNA sequenced on
ABI3730XL sequencer (Macrogen, Seoul, South Korea).
The sequencing was done using species specific primers
i.e. EH-1/EH-2 for E. histolytica. All sequences were ana-
lyzed for homology by using the nucleotide-nucleotide
BLAST search feature [43].
The identity between the sequencing results of PCR prod-
uct of E. histolytica from liver abscess pus and urine with
the sequence deposited in GenBank [accession number:
X56991] were analyzed by using the "Align two sequences
(bl2seq)" feature [43].
Assessment of competition of non target DNA
During the standardization to assess the competition of
other non target DNA present in liver abscess pus and
urine specimen with target DNA, the nested multiplex
PCR was checked with reference DNA (DNA from stand-
ard culture of E. histolytica,  E. dispar &E. moshkovskii)
spiked with DNA from liver abscess pus (PLA pus negative
for E. histolytica) and urine (negative control group) fol-
lowed by nested multiplex PCR amplification.
Estimation of minimum number of Entamoeba cells 
detectable by nested multiplex PCR
This was performed for E. histolytica with Locke-egg (LE)
medium (NIH modification of Boeck and Drbohlav's
medium) liver abscess pus cultures; the amoebae were
counted using a standard haemocytometer. A cell pellet
containing 106 cells was preferred for determining the
detection limit of nested multiplex PCR for E. histolytica.
The cell pellet containing 106 cells of E. histolytica was
diluted 10 folds in phosphate buffer saline (PBS) to
obtain different concentration of cells, such as 105, 104,
103, 102 and 10 cells/ml. The different dilutions of cells
ranging from 106 to 10 cells/ml were centrifuged and the
remaining pellet of each dilution was added to 0.05 μl of
liver abscess pus (PLA pus negative for E. histolytica) fol-
lowed by DNA extraction and PCR as per the aforemen-
tioned protocol.
Statistical data analysis
Sensitivity was calculated as follows: number of patients
with positive test results/total number of patients × 100.
Specificity was calculated as follows: number of controls
with negative test results/total number of controls × 100.
The positive predictive value was calculated as follows:
number of true positives/(number of true positives +
number of false positives) × 100. The negative predictive
value was calculated as follows: number of true negatives/
(number of true negatives + number of false negatives) ×
100. The agreement between the tests was calculated using
the Kappa statistics. To determine the statistical signifi-
cance of differences between the proportions, Chi-square
(χ2) test and Fisher's exact test were used. The χ2 test and
odds ratio were found using "Epi Info Version 6". To cal-
culate the significance of the difference in sensitivities,
McNemar's Chi-square test was applied. The McNemar's
test was performed using "Graph Pad Software".
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